Cumberland Pharmaceuticals Email Format

Pharmaceutical ManufacturingTennessee, United States51-200 Employees

Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes FDA-approved branded prescription products. It is publicly listed and headquartered in Nashville, Tennessee, described as the largest publicly listed biopharmaceutical company founded and headquartered there. The firm collaborates with Vanderbilt University and Vanderbilt University Medical Center on a growing slate of research and development programs.

Its commercial organization supports branded products in the U.S., while a development team pursues new medicines for the future, with a focus on underserved niche markets and products that may help reduce costs for providers and patients. In May 2026, the company announced the launch of Vibativ (telavancin) injection in China, following regulatory approval and a strategic partnership with SciClone Pharmaceuticals.

Sign up for free to view info

Company overview Employee directory